John H. Runne

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…

Davis Polk advised the sole underwriter in connection with a $201.25 million SEC-registered offering of 3,220,000 shares of common stock of Pinnacle Financial Partners, Inc. Included…

Davis Polk advised the joint lead dealer managers in connection with the registered offers by Johnson Controls International plc (“JCI plc”) to exchange certain outstanding debt securities…

Davis Polk advised Communications Sales & Leasing, Inc., as issuer, and CSL Capital, LLC, as co-issuer, in connection with the Rule 144A/Regulation S offering of $400 million aggregate…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering by Gran Tierra Energy Inc. of…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Xylem Inc. of $500 million aggregate principal amount of its 3.250% senior notes due…

Davis Polk advised the representative of the initial purchasers in connection with a Regulation S/Rule 144A offering of $400 million aggregate principal amount of PDC Energy, Inc.’s 6.125%…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…

Davis Polk advised Communications Sales & Leasing, Inc. (“CS&L”), as issuer, in connection with an SEC-registered at-the-market offering program by CS&L under which CS&L may…